Investors & Media
Corporate Profile
Kronos Bio is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting deregulated transcription. Led by an experienced management team that possesses deep expertise in transcriptional regulation, computational and chemical biology, drug discovery platform technologies, and computational and medicinal chemistry, we have developed a robust pipeline.
Market Cap
$
Data Provided by Refinitiv. Minimum 15 minutes delayed.
